Figure 2.

Tumor marker trends and clinical timeline. Panel A shows changes in CA125, CA15-3, CYFRA21-1, and NSE during the disease course. Panel B summarizes the main diagnostic, therapeutic, progression, and outcome events.

Tumor marker trends and clinical timeline. Panel A shows changes in CA125, CA15-3, CYFRA21-1, and NSE during the disease course. Panel B summarizes the main diagnostic, therapeutic, progression, and outcome events.